Review



ryr1 arr 001 rabbit polyclonal  (Alomone Labs)


Bioz Verified Symbol Alomone Labs is a verified supplier
Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Alomone Labs ryr1 arr 001 rabbit polyclonal
    Ryr1 Arr 001 Rabbit Polyclonal, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 18 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ryr1 arr 001 rabbit polyclonal/product/Alomone Labs
    Average 93 stars, based on 18 article reviews
    ryr1 arr 001 rabbit polyclonal - by Bioz Stars, 2026-02
    93/100 stars

    Images



    Similar Products

    93
    Alomone Labs ryr1 arr 001 rabbit polyclonal
    Ryr1 Arr 001 Rabbit Polyclonal, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ryr1 arr 001 rabbit polyclonal/product/Alomone Labs
    Average 93 stars, based on 1 article reviews
    ryr1 arr 001 rabbit polyclonal - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    89
    Thermo Fisher gene exp ryr1 hs00166991 m1
    Gene Exp Ryr1 Hs00166991 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 89/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gene exp ryr1 hs00166991 m1/product/Thermo Fisher
    Average 89 stars, based on 1 article reviews
    gene exp ryr1 hs00166991 m1 - by Bioz Stars, 2026-02
    89/100 stars
      Buy from Supplier

    93
    Proteintech ryr1
    Ryr1, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ryr1/product/Proteintech
    Average 93 stars, based on 1 article reviews
    ryr1 - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    Proteintech 1 ap
    1 Ap, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/1 ap/product/Proteintech
    Average 93 stars, based on 1 article reviews
    1 ap - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    96
    New England Biolabs ryr1 e3212 l4788
    (A) <t>RyR1</t> is a calcium release channel located on the membrane of the endoplasmic reticulum (ER). (B) Experimental method for monitoring intracellular calcium ([Ca 2+ ]i). (C) Quantification of the intracellular calcium signal. F 0 represents the averaged intensity of baseline fluorescence, whereas F max represents the peak intensity following the drug administration. (D–F) Caffeine responses for RyR1, <t>RyR2,</t> and <t>RyR3.</t> The time-course reaction ( F/F 0 ) and the peak ( F max / F 0 ) are plotted for conditions with and without expression. Caffeine was administered after measuring the baseline fluorescence for 30 s, as shown by the arrows. N = 4. (G–I) Response of RyR1, RyR2, and RyR3 to isoflurane. N = 4. (J–L) Response of RyR1, RyR2, and RyR3 to sevoflurane. N = 4. (M–O) Response of RyR1, RyR2, and RyR3 to halothane. N = 4. (P–R) Response of RyR1, RyR2, and RyR3 to chloroform. N = 6. (S) Normalized peak intensity for each anesthetic (1.25 mM). Data are normalized so that the peaks of 2.50 mM caffeine and the control (without pharmacological agents) are 1.0 and 0, respectively, for each isoform (equation in Materials and methods). N = 4–6. (T) RyR1-selective index. I x represents the normalized peak intensity at 1.25 mM anesthetics for each isoform. N = 4–6. Data are represented as Mean ± SD. For the insets of panels D – R , the data were fitted with logistic functions (equation in Materials and methods). RyR1, the type 1 <t>ryanodine</t> <t>receptor;</t> ER, endoplasmic reticulum; RyR2, the type 2 ryanodine receptor; RyR3, the type 3 ryanodine receptor; Caf., Caffeine; Iso., Isoflurane; Sevo., Sevoflurane; Halo., Halothane.
    Ryr1 E3212 L4788, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ryr1 e3212 l4788/product/New England Biolabs
    Average 96 stars, based on 1 article reviews
    ryr1 e3212 l4788 - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc d4e1 anti ryr1 antibody
    (A) <t>RyR1</t> is a calcium release channel located on the membrane of the endoplasmic reticulum (ER). (B) Experimental method for monitoring intracellular calcium ([Ca 2+ ]i). (C) Quantification of the intracellular calcium signal. F 0 represents the averaged intensity of baseline fluorescence, whereas F max represents the peak intensity following the drug administration. (D–F) Caffeine responses for RyR1, <t>RyR2,</t> and <t>RyR3.</t> The time-course reaction ( F/F 0 ) and the peak ( F max / F 0 ) are plotted for conditions with and without expression. Caffeine was administered after measuring the baseline fluorescence for 30 s, as shown by the arrows. N = 4. (G–I) Response of RyR1, RyR2, and RyR3 to isoflurane. N = 4. (J–L) Response of RyR1, RyR2, and RyR3 to sevoflurane. N = 4. (M–O) Response of RyR1, RyR2, and RyR3 to halothane. N = 4. (P–R) Response of RyR1, RyR2, and RyR3 to chloroform. N = 6. (S) Normalized peak intensity for each anesthetic (1.25 mM). Data are normalized so that the peaks of 2.50 mM caffeine and the control (without pharmacological agents) are 1.0 and 0, respectively, for each isoform (equation in Materials and methods). N = 4–6. (T) RyR1-selective index. I x represents the normalized peak intensity at 1.25 mM anesthetics for each isoform. N = 4–6. Data are represented as Mean ± SD. For the insets of panels D – R , the data were fitted with logistic functions (equation in Materials and methods). RyR1, the type 1 <t>ryanodine</t> <t>receptor;</t> ER, endoplasmic reticulum; RyR2, the type 2 ryanodine receptor; RyR3, the type 3 ryanodine receptor; Caf., Caffeine; Iso., Isoflurane; Sevo., Sevoflurane; Halo., Halothane.
    D4e1 Anti Ryr1 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/d4e1 anti ryr1 antibody/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    d4e1 anti ryr1 antibody - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    93
    Proteintech ryanodine receptor
    (A) <t>RyR1</t> is a calcium release channel located on the membrane of the endoplasmic reticulum (ER). (B) Experimental method for monitoring intracellular calcium ([Ca 2+ ]i). (C) Quantification of the intracellular calcium signal. F 0 represents the averaged intensity of baseline fluorescence, whereas F max represents the peak intensity following the drug administration. (D–F) Caffeine responses for RyR1, <t>RyR2,</t> and <t>RyR3.</t> The time-course reaction ( F/F 0 ) and the peak ( F max / F 0 ) are plotted for conditions with and without expression. Caffeine was administered after measuring the baseline fluorescence for 30 s, as shown by the arrows. N = 4. (G–I) Response of RyR1, RyR2, and RyR3 to isoflurane. N = 4. (J–L) Response of RyR1, RyR2, and RyR3 to sevoflurane. N = 4. (M–O) Response of RyR1, RyR2, and RyR3 to halothane. N = 4. (P–R) Response of RyR1, RyR2, and RyR3 to chloroform. N = 6. (S) Normalized peak intensity for each anesthetic (1.25 mM). Data are normalized so that the peaks of 2.50 mM caffeine and the control (without pharmacological agents) are 1.0 and 0, respectively, for each isoform (equation in Materials and methods). N = 4–6. (T) RyR1-selective index. I x represents the normalized peak intensity at 1.25 mM anesthetics for each isoform. N = 4–6. Data are represented as Mean ± SD. For the insets of panels D – R , the data were fitted with logistic functions (equation in Materials and methods). RyR1, the type 1 <t>ryanodine</t> <t>receptor;</t> ER, endoplasmic reticulum; RyR2, the type 2 ryanodine receptor; RyR3, the type 3 ryanodine receptor; Caf., Caffeine; Iso., Isoflurane; Sevo., Sevoflurane; Halo., Halothane.
    Ryanodine Receptor, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ryanodine receptor/product/Proteintech
    Average 93 stars, based on 1 article reviews
    ryanodine receptor - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    Image Search Results


    (A) RyR1 is a calcium release channel located on the membrane of the endoplasmic reticulum (ER). (B) Experimental method for monitoring intracellular calcium ([Ca 2+ ]i). (C) Quantification of the intracellular calcium signal. F 0 represents the averaged intensity of baseline fluorescence, whereas F max represents the peak intensity following the drug administration. (D–F) Caffeine responses for RyR1, RyR2, and RyR3. The time-course reaction ( F/F 0 ) and the peak ( F max / F 0 ) are plotted for conditions with and without expression. Caffeine was administered after measuring the baseline fluorescence for 30 s, as shown by the arrows. N = 4. (G–I) Response of RyR1, RyR2, and RyR3 to isoflurane. N = 4. (J–L) Response of RyR1, RyR2, and RyR3 to sevoflurane. N = 4. (M–O) Response of RyR1, RyR2, and RyR3 to halothane. N = 4. (P–R) Response of RyR1, RyR2, and RyR3 to chloroform. N = 6. (S) Normalized peak intensity for each anesthetic (1.25 mM). Data are normalized so that the peaks of 2.50 mM caffeine and the control (without pharmacological agents) are 1.0 and 0, respectively, for each isoform (equation in Materials and methods). N = 4–6. (T) RyR1-selective index. I x represents the normalized peak intensity at 1.25 mM anesthetics for each isoform. N = 4–6. Data are represented as Mean ± SD. For the insets of panels D – R , the data were fitted with logistic functions (equation in Materials and methods). RyR1, the type 1 ryanodine receptor; ER, endoplasmic reticulum; RyR2, the type 2 ryanodine receptor; RyR3, the type 3 ryanodine receptor; Caf., Caffeine; Iso., Isoflurane; Sevo., Sevoflurane; Halo., Halothane.

    Journal: PLOS Biology

    Article Title: Isoflurane activates the type 1 ryanodine receptor to induce anesthesia in mice

    doi: 10.1371/journal.pbio.3003172

    Figure Lengend Snippet: (A) RyR1 is a calcium release channel located on the membrane of the endoplasmic reticulum (ER). (B) Experimental method for monitoring intracellular calcium ([Ca 2+ ]i). (C) Quantification of the intracellular calcium signal. F 0 represents the averaged intensity of baseline fluorescence, whereas F max represents the peak intensity following the drug administration. (D–F) Caffeine responses for RyR1, RyR2, and RyR3. The time-course reaction ( F/F 0 ) and the peak ( F max / F 0 ) are plotted for conditions with and without expression. Caffeine was administered after measuring the baseline fluorescence for 30 s, as shown by the arrows. N = 4. (G–I) Response of RyR1, RyR2, and RyR3 to isoflurane. N = 4. (J–L) Response of RyR1, RyR2, and RyR3 to sevoflurane. N = 4. (M–O) Response of RyR1, RyR2, and RyR3 to halothane. N = 4. (P–R) Response of RyR1, RyR2, and RyR3 to chloroform. N = 6. (S) Normalized peak intensity for each anesthetic (1.25 mM). Data are normalized so that the peaks of 2.50 mM caffeine and the control (without pharmacological agents) are 1.0 and 0, respectively, for each isoform (equation in Materials and methods). N = 4–6. (T) RyR1-selective index. I x represents the normalized peak intensity at 1.25 mM anesthetics for each isoform. N = 4–6. Data are represented as Mean ± SD. For the insets of panels D – R , the data were fitted with logistic functions (equation in Materials and methods). RyR1, the type 1 ryanodine receptor; ER, endoplasmic reticulum; RyR2, the type 2 ryanodine receptor; RyR3, the type 3 ryanodine receptor; Caf., Caffeine; Iso., Isoflurane; Sevo., Sevoflurane; Halo., Halothane.

    Article Snippet: Otherwise, the pUC118 vector containing the coding sequence of RyR1 E3212-L4788 (approximately 4.7 kbp) was used with AvrII and ClaI digestion (New England Biolabs).

    Techniques: Membrane, Fluorescence, Expressing, Control

    (A) Transient transfection of RyR1, RyR2, and the chimeric receptors (ChR.1-3, ChR.1′-3′) into HEK 293T cells. The time-course reaction ( F/F 0 ) and the peak of the isoflurane response normalized by the caffeine response are shown. N = 4. (B) The RyR1-RyR2 chimeric receptor 10 (ChR.10) and ChR.10′. N = 4. (C) The chimeric receptors, ChR.10, ChR.13, ChR.13-6, and the amino acid substitution mutants. N = 8. (D) Normalized isoflurane responses of M4000 mutants with single amino acid substitutions. The amino acid substitution was color-coded as follows: cyan for basic amino acids; red for acidic amino acids; orange for amino acids with polar uncharged side chains; green for amino acids with alkyl chains; and purple for amino acids with aromatic rings. N = 4–12. (E) Time-course reaction and normalized isoflurane response of RyR1(M4000F). N = 4. (F) Stable cell lines that express RyR1(WT) and RyR1(M4000F). Basal buffer without pharmacological agents, 1.25 mM caffeine, or 0.63 mM anesthetics (isoflurane, sevoflurane, and halothane) were given. N = 4. Data are represented as Mean ± SD. ** Adjusted P -values (Adj. P ) < 0.01 by the Steel’s test (multiple comparisons between RyR1 and other groups). For the calculation of the Normalized Iso. Response (equation 1 in Materials and methods), the peaks at 5.0 mM caffeine and the control (without pharmacological agents) were normalized to 1.0 and 0, respectively, in the transient expression experiment (A–E) , while the peaks at 1.25 mM caffeine and the control were 1.0 and 0, respectively, in the experiments with stable cell lines (F) . ChR., Chimeric receptor; RyR1, the type 1 ryanodine receptor; RyR2, the type 2 ryanodine receptor; Caf., Caffeine; Iso., Isoflurane; Sevo., Sevoflurane; Halo., Halothane.

    Journal: PLOS Biology

    Article Title: Isoflurane activates the type 1 ryanodine receptor to induce anesthesia in mice

    doi: 10.1371/journal.pbio.3003172

    Figure Lengend Snippet: (A) Transient transfection of RyR1, RyR2, and the chimeric receptors (ChR.1-3, ChR.1′-3′) into HEK 293T cells. The time-course reaction ( F/F 0 ) and the peak of the isoflurane response normalized by the caffeine response are shown. N = 4. (B) The RyR1-RyR2 chimeric receptor 10 (ChR.10) and ChR.10′. N = 4. (C) The chimeric receptors, ChR.10, ChR.13, ChR.13-6, and the amino acid substitution mutants. N = 8. (D) Normalized isoflurane responses of M4000 mutants with single amino acid substitutions. The amino acid substitution was color-coded as follows: cyan for basic amino acids; red for acidic amino acids; orange for amino acids with polar uncharged side chains; green for amino acids with alkyl chains; and purple for amino acids with aromatic rings. N = 4–12. (E) Time-course reaction and normalized isoflurane response of RyR1(M4000F). N = 4. (F) Stable cell lines that express RyR1(WT) and RyR1(M4000F). Basal buffer without pharmacological agents, 1.25 mM caffeine, or 0.63 mM anesthetics (isoflurane, sevoflurane, and halothane) were given. N = 4. Data are represented as Mean ± SD. ** Adjusted P -values (Adj. P ) < 0.01 by the Steel’s test (multiple comparisons between RyR1 and other groups). For the calculation of the Normalized Iso. Response (equation 1 in Materials and methods), the peaks at 5.0 mM caffeine and the control (without pharmacological agents) were normalized to 1.0 and 0, respectively, in the transient expression experiment (A–E) , while the peaks at 1.25 mM caffeine and the control were 1.0 and 0, respectively, in the experiments with stable cell lines (F) . ChR., Chimeric receptor; RyR1, the type 1 ryanodine receptor; RyR2, the type 2 ryanodine receptor; Caf., Caffeine; Iso., Isoflurane; Sevo., Sevoflurane; Halo., Halothane.

    Article Snippet: Otherwise, the pUC118 vector containing the coding sequence of RyR1 E3212-L4788 (approximately 4.7 kbp) was used with AvrII and ClaI digestion (New England Biolabs).

    Techniques: Transfection, Stable Transfection, Control, Expressing

    (A, B) Putative binding formation with 4-chloro-m-cresol (4-CmC) (A) and isoflurane (B). (C) Time-course reaction to 4-CmC, isoflurane, and caffeine of each amino acid substitution mutant. N = 4. (D) Normalized peak intensity of responses to 4-CmC and isoflurane for each amino acid substitution mutant. N = 4. The data are normalized so that the peaks of 5.0 mM caffeine and the control (without pharmacological agents) are 1.0 and 0, respectively (equation 1 in Materials and methods). Data are represented as Mean ± SD. 4-CmC, 4-chloro-m-cresol; RyR1, the type 1 ryanodine receptor; WT, wild-type; Caf., Caffeine; Iso., Isoflurane.

    Journal: PLOS Biology

    Article Title: Isoflurane activates the type 1 ryanodine receptor to induce anesthesia in mice

    doi: 10.1371/journal.pbio.3003172

    Figure Lengend Snippet: (A, B) Putative binding formation with 4-chloro-m-cresol (4-CmC) (A) and isoflurane (B). (C) Time-course reaction to 4-CmC, isoflurane, and caffeine of each amino acid substitution mutant. N = 4. (D) Normalized peak intensity of responses to 4-CmC and isoflurane for each amino acid substitution mutant. N = 4. The data are normalized so that the peaks of 5.0 mM caffeine and the control (without pharmacological agents) are 1.0 and 0, respectively (equation 1 in Materials and methods). Data are represented as Mean ± SD. 4-CmC, 4-chloro-m-cresol; RyR1, the type 1 ryanodine receptor; WT, wild-type; Caf., Caffeine; Iso., Isoflurane.

    Article Snippet: Otherwise, the pUC118 vector containing the coding sequence of RyR1 E3212-L4788 (approximately 4.7 kbp) was used with AvrII and ClaI digestion (New England Biolabs).

    Techniques: Binding Assay, Mutagenesis, Control

    (A) Amino acid sequence around M4000 (rabbit RyR1) and the generation of RyR1(M4003F) KI mice. (B) The genomic sequences of the KI site for each genotype. (C) Dose–response curves for isoflurane-induced loss of righting reflex (LORR). Data were fitted with logistic functions (equation 5 in Materials and methods). N = 11 (WT), 14 (heterozygous [Hetero] KI), and 13 (homozygous [Homo] KI). The shaded regions represent 95% CIs. (D) Comparison of the concentrations at which the mice reached LORR (Mean ± SD with individual data points). N = 11 (WT), 14 (Hetero KI), and 13 (Homo KI). The adjusted P -values (Adj. P ) by the Dunnett’s test are shown. (E) Representative transition of EEG signals, the spectrograms, and EMG signals during isoflurane treatment. At the baseline, mice were kept awake by gentle handling. (F) Normalized delta power (0.4–4 Hz) on EEG during isoflurane treatment for each animal. The mean values and individual data are shown. N = 8 (WT), 10 (Hetero KI), and 9 (Homo KI). (G) Changes in delta power over the baseline (0.0% isoflurane). Mean ± SD is shown. N = 8 (WT), 10 (Hetero KI), and 9 (Homo KI). Data were fitted using logistic functions (equation 6 in Materials and methods). RyR1, the type 1 ryanodine receptor; ssODN, single-stranded oligodeoxynucleotide; WT, wild-type; Hetero, heterozygous; Homo, homozygous; PAM, protospacer-adjacent motif; Iso., Isoflurane; LORR, loss of righting reflex; EEG, electroencephalogram; EMG, electromyogram; The mice illustration was modified from Openclipart ( https://openclipart.org/ ).

    Journal: PLOS Biology

    Article Title: Isoflurane activates the type 1 ryanodine receptor to induce anesthesia in mice

    doi: 10.1371/journal.pbio.3003172

    Figure Lengend Snippet: (A) Amino acid sequence around M4000 (rabbit RyR1) and the generation of RyR1(M4003F) KI mice. (B) The genomic sequences of the KI site for each genotype. (C) Dose–response curves for isoflurane-induced loss of righting reflex (LORR). Data were fitted with logistic functions (equation 5 in Materials and methods). N = 11 (WT), 14 (heterozygous [Hetero] KI), and 13 (homozygous [Homo] KI). The shaded regions represent 95% CIs. (D) Comparison of the concentrations at which the mice reached LORR (Mean ± SD with individual data points). N = 11 (WT), 14 (Hetero KI), and 13 (Homo KI). The adjusted P -values (Adj. P ) by the Dunnett’s test are shown. (E) Representative transition of EEG signals, the spectrograms, and EMG signals during isoflurane treatment. At the baseline, mice were kept awake by gentle handling. (F) Normalized delta power (0.4–4 Hz) on EEG during isoflurane treatment for each animal. The mean values and individual data are shown. N = 8 (WT), 10 (Hetero KI), and 9 (Homo KI). (G) Changes in delta power over the baseline (0.0% isoflurane). Mean ± SD is shown. N = 8 (WT), 10 (Hetero KI), and 9 (Homo KI). Data were fitted using logistic functions (equation 6 in Materials and methods). RyR1, the type 1 ryanodine receptor; ssODN, single-stranded oligodeoxynucleotide; WT, wild-type; Hetero, heterozygous; Homo, homozygous; PAM, protospacer-adjacent motif; Iso., Isoflurane; LORR, loss of righting reflex; EEG, electroencephalogram; EMG, electromyogram; The mice illustration was modified from Openclipart ( https://openclipart.org/ ).

    Article Snippet: Otherwise, the pUC118 vector containing the coding sequence of RyR1 E3212-L4788 (approximately 4.7 kbp) was used with AvrII and ClaI digestion (New England Biolabs).

    Techniques: Sequencing, Genomic Sequencing, Comparison, Gentle, Modification

    (A) AAV-mediated expression in the brain. (B) Dose–response curves for loss of righting reflex (LORR) of mice expressing mCherry or RyR1-BsSV. Data were fitted with logistic functions (equation 5 in Materials and methods). N = 18 for each group. The shaded regions represent 95% CIs. (C) Comparison of the concentrations at which mice reach LORR (Mean ± SD with individual data points). N = 18 for each group. The P -value by the Student t test is shown. (D) Cultures of cortical neurons on HD-MEA. (E, F) Representative raster plots and the total spike counts in baseline (E) and the isoflurane treatment (2.1% isoflurane) (F). (G) Raster plots across the sequential exposure to isoflurane and the recovery for mCherry and RyR1-BsSV expressions. The above black bars represent the detected prolonged burst periods. Four independent wells are indicated, respectively. The extracellular calcium concentration was adjusted to 2.0 mM before the experiment. (H) Duration of the prolonged burst periods. Data are presented as Mean ± SD with individual data points. N = 4 for both mCherry (gray) and RyR1-BsSV (red) expressions. * P < 0.05 by the two-sample Wilcoxon test. Camk2a, Ca 2+ /calmodulin-dependent protein kinase II α; AAV, adeno-associated virus; RyR1-BsSV, brain-specific splicing variant of the type 1 ryanodine receptor; Iso., Isoflurane; LORR, loss of righting reflex; HD-MEA, high-density multielectrode array; Recov., Recovery. The mice illustration was modified from Openclipart ( https://openclipart.org/ ).

    Journal: PLOS Biology

    Article Title: Isoflurane activates the type 1 ryanodine receptor to induce anesthesia in mice

    doi: 10.1371/journal.pbio.3003172

    Figure Lengend Snippet: (A) AAV-mediated expression in the brain. (B) Dose–response curves for loss of righting reflex (LORR) of mice expressing mCherry or RyR1-BsSV. Data were fitted with logistic functions (equation 5 in Materials and methods). N = 18 for each group. The shaded regions represent 95% CIs. (C) Comparison of the concentrations at which mice reach LORR (Mean ± SD with individual data points). N = 18 for each group. The P -value by the Student t test is shown. (D) Cultures of cortical neurons on HD-MEA. (E, F) Representative raster plots and the total spike counts in baseline (E) and the isoflurane treatment (2.1% isoflurane) (F). (G) Raster plots across the sequential exposure to isoflurane and the recovery for mCherry and RyR1-BsSV expressions. The above black bars represent the detected prolonged burst periods. Four independent wells are indicated, respectively. The extracellular calcium concentration was adjusted to 2.0 mM before the experiment. (H) Duration of the prolonged burst periods. Data are presented as Mean ± SD with individual data points. N = 4 for both mCherry (gray) and RyR1-BsSV (red) expressions. * P < 0.05 by the two-sample Wilcoxon test. Camk2a, Ca 2+ /calmodulin-dependent protein kinase II α; AAV, adeno-associated virus; RyR1-BsSV, brain-specific splicing variant of the type 1 ryanodine receptor; Iso., Isoflurane; LORR, loss of righting reflex; HD-MEA, high-density multielectrode array; Recov., Recovery. The mice illustration was modified from Openclipart ( https://openclipart.org/ ).

    Article Snippet: Otherwise, the pUC118 vector containing the coding sequence of RyR1 E3212-L4788 (approximately 4.7 kbp) was used with AvrII and ClaI digestion (New England Biolabs).

    Techniques: Expressing, Comparison, Concentration Assay, Virus, Variant Assay, Modification

    (A) Scheme of the chemical screening. Following in silico screening, the agonistic actions of some of the hit compounds were tested with tetracycline-induced expressions of RyR1(WT) and RyR1(M4000F). (B) Results of the in vitro screening. As controls, stimulations by caffeine, isoflurane, and basal buffer without chemicals were included. 4-bromophenol (4-BP) is identified as a hit compound. (C) Putative binding formation of 4-BP. (D) Dose-dependent effects of 4-BP and the isomers 3-BP and 2-BP on RyR1(WT), RyR1(M4000F), RyR2, and RyR3. Data were fitted using logistic functions (equation 4 in Materials and methods). N = 4. ( E , F ) Effects of methyl phenols (MPs) (E) and ethyl phenols (EPs) (F) on RyR1. N = 5. (G) Effects of a series of 4-alkylphenols on RyR1, RyR2, and RyR3. N = 5. (H) Effects of 4-MP, 4-EP, and 4-PP on RyR1(WT) and RyR1(M4000F). The time-course reactions and the peak intensities are shown, respectively. N = 4. Data are presented as Mean ± SD. RyR1 and the M4000F mutant were expressed through tetracycline induction in the stable cell lines except for the data shown in panel H . RyR1, the type 1 ryanodine receptor; F max / F 0 , the maximum fluorescence intensity; 4-BP, 4-bromophenol; RyR2, the type 2 ryanodine receptor; RyR3, the type 3 ryanodine receptor; 4-BP, 4-bromophenol; 3-BP, 3-bromophenol; 2-BP, 2-bromophenol; 4-MP, 4-methylphenol; 3-MP, 3-methylphenol; 2-MP, 2-methylphenol; 4-EP, 4-ethylphenol; 3-EP, 3-ethylphenol; 2-EP, 2-ethylphenol; 4-PP, 4-propylphenol; Caf., Caffeine.

    Journal: PLOS Biology

    Article Title: Isoflurane activates the type 1 ryanodine receptor to induce anesthesia in mice

    doi: 10.1371/journal.pbio.3003172

    Figure Lengend Snippet: (A) Scheme of the chemical screening. Following in silico screening, the agonistic actions of some of the hit compounds were tested with tetracycline-induced expressions of RyR1(WT) and RyR1(M4000F). (B) Results of the in vitro screening. As controls, stimulations by caffeine, isoflurane, and basal buffer without chemicals were included. 4-bromophenol (4-BP) is identified as a hit compound. (C) Putative binding formation of 4-BP. (D) Dose-dependent effects of 4-BP and the isomers 3-BP and 2-BP on RyR1(WT), RyR1(M4000F), RyR2, and RyR3. Data were fitted using logistic functions (equation 4 in Materials and methods). N = 4. ( E , F ) Effects of methyl phenols (MPs) (E) and ethyl phenols (EPs) (F) on RyR1. N = 5. (G) Effects of a series of 4-alkylphenols on RyR1, RyR2, and RyR3. N = 5. (H) Effects of 4-MP, 4-EP, and 4-PP on RyR1(WT) and RyR1(M4000F). The time-course reactions and the peak intensities are shown, respectively. N = 4. Data are presented as Mean ± SD. RyR1 and the M4000F mutant were expressed through tetracycline induction in the stable cell lines except for the data shown in panel H . RyR1, the type 1 ryanodine receptor; F max / F 0 , the maximum fluorescence intensity; 4-BP, 4-bromophenol; RyR2, the type 2 ryanodine receptor; RyR3, the type 3 ryanodine receptor; 4-BP, 4-bromophenol; 3-BP, 3-bromophenol; 2-BP, 2-bromophenol; 4-MP, 4-methylphenol; 3-MP, 3-methylphenol; 2-MP, 2-methylphenol; 4-EP, 4-ethylphenol; 3-EP, 3-ethylphenol; 2-EP, 2-ethylphenol; 4-PP, 4-propylphenol; Caf., Caffeine.

    Article Snippet: Otherwise, the pUC118 vector containing the coding sequence of RyR1 E3212-L4788 (approximately 4.7 kbp) was used with AvrII and ClaI digestion (New England Biolabs).

    Techniques: In Silico, In Vitro, Binding Assay, Mutagenesis, Stable Transfection, Fluorescence